Sheri Louise Dodd net worth and biography

Sheri Dodd Biography and Net Worth

Sheri L. Dodd joined Tactile Medical in July of 2024 as Chief Executive Officer where she has also been a member of the board since 2021. Most recently, Ms. Dodd served as President, Medtronic Canada at Medtronic plc. In her role she was responsible for all commercial activities related to the sale and distribution of the Medtronic portfolio in Canada. She joined Medtronic in March 2010 and served in functional vice president positions including healthcare economics and market access; clinical research, health economics and policy; and general management positions for non-intensive diabetes therapies and telehealth. From November 1997 until March 2010, Ms. Dodd held various positions with Johnson & Johnson, most recently as vice president of health economics and reimbursement for Ethicon, Inc. Ms. Dodd also served as an outcomes researcher with Orthopedic Surgeons, plc from January 1995 until November 1997. From May 1988 until September 1993, Ms. Dodd served as a project manager with the World Health Organization.

What is Sheri Louise Dodd's net worth?: The estimated net worth of Sheri Louise Dodd is at least $6.68 million as of February 24th, 2026. Dodd owns 243,885 shares of Tactile Systems Technology stock worth more than $6,676,352 as of March 17th. This net worth estimate does not reflect any other investments that Dodd may own. Learn More about Sheri Louise Dodd's net worth.
How do I contact Sheri Louise Dodd?: The corporate mailing address for Dodd and other Tactile Systems Technology executives is 3701 Wayzata Blvd Suite 300, MINNEAPOLIS MN, 55413. Tactile Systems Technology can also be reached via phone at (612) 355-5100 and via email at [email protected]. Learn More on Sheri Louise Dodd's contact information.
Has Sheri Louise Dodd been buying or selling shares of Tactile Systems Technology?: During the past quarter, Sheri Louise Dodd has sold $749,429.42 in shares of Tactile Systems Technology stock. Most recently, Sheri Louise Dodd sold 10,993 shares of the business's stock in a transaction on Tuesday, February 24th. The shares were sold at an average price of $28.94, for a transaction totalling $318,137.42. Following the completion of the sale, the chief executive officer now directly owns 243,885 shares of the company's stock, valued at $7,058,031.90. Learn More on Sheri Louise Dodd's trading history.
Who are Tactile Systems Technology's active insiders?: Tactile Systems Technology's insider roster includes Elaine Birkemeyer (CFO), William Burke (Director), Kristie Burns (VP), Sheri Dodd (CEO), and Daniel Reuvers (CEO). Learn More on Tactile Systems Technology's active insiders.
Are insiders buying or selling shares of Tactile Systems Technology?: In the last year, insiders at the sold shares 10 times. They sold a total of 69,259 shares worth more than $1,739,982.91. The most recent insider tranaction occured on February, 24th when CEO Sheri Louise Dodd sold 10,993 shares worth more than $318,137.42. Insiders at Tactile Systems Technology own 2.5% of the company. Learn More about insider trades at Tactile Systems Technology.
Information on this page was last updated on 2/24/2026.

Sheri Louise Dodd Insider Trading History at Tactile Systems Technology

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/24/2026	Sell	10,993	$28.94	$318,137.42	243,885
2/23/2026	Sell	15,240	$28.30	$431,292.00	254,878
8/8/2025	Sell	7,762	$12.36	$95,938.32	173,479

Sheri Louise Dodd Buying and Selling Activity at Tactile Systems Technology

Tactile Systems Technology Company Overview

Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers. The company also provides Kylee, a mobile application to help patients learn about lymphedema, track their symptoms, and treatment, as well as to share their progress with their doctor; and AffloVest, a portable high frequency chest wall oscillation vest to treat patients with retained pulmonary secretions resulting from bronchiectasis, cystic fibrosis, and various neuromuscular disorders. Tactile Systems Technology, Inc. was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.

Today's Range

Now: $27.37

$27.16

$27.99

50 Day Range

MA: $28.94

$26.45

$33.05

2 Week Range

Now: $27.37

$8.61

$37.77

Volume

130,906 shs

Average Volume

356,441 shs

Market Capitalization

$622.67 million

P/E Ratio

32.97

Dividend Yield

N/A

Beta

0.97